Rational development of novel treatment regimens to improve the efficacy of estrogen therapy in anti-estrogen-resistant ER plus breast cancer

被引：0
|
作者：
Traphagen, Nicole A. [1 ]
Jiang, Amanda [2 ]
Hosford, Sarah R. [1 ]
Miller, Todd W. [1 ]
机构：
[1] Dartmouth Geisel Sch Med, Lebanon, NH USA
[2] Dartmouth Coll, Hanover, NH 03755 USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-4359
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4359
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Epigenetic mechanisms of cancer progression and therapy resistance in estrogen-receptor (ER plus ) breast cancer
    Toska, Eneda
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2024, 1879 (03):
  • [22] Estrogen (E2)/anti-estrogen driven estrogen receptor (ER) transcription complex assembly in resistant human breast cancer cell lines
    Naughton, C
    Kuske, B
    MacLeod, K
    Langdon, SP
    Smyth, JF
    Cameron, DA
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S246 - S246
  • [23] Novel Selective Estrogen Mimics for the Treatment of Tamoxifen-Resistant Breast Cancer
    Molloy, Mary Ellen
    White, Bethany E. Perez
    Gherezghiher, Teshome
    Michalsen, Bradley T.
    Xiong, Rui
    Patel, Hitisha
    Zhao, Huiping
    Maximov, Philipp Y.
    Jordan, V. Craig
    Thatcher, Gregory R. J.
    Tonetti, Debra A.
    MOLECULAR CANCER THERAPEUTICS, 2014, 13 (11) : 2515 - 2526
  • [24] Pitfalls in preclinical development of immunotherapies for ER plus breast cancer: estrogen as an immunomodulator potentially influencing pembrolizumab efficacy in a breast cancer model in humanized mice
    Kahkonen, Tiina
    Suominen, Mari
    Maki-Jouppila, Jenni
    Yatkin, Emrah
    Dube, Philip
    Tanaka, Azusa
    Halleen, Jussi
    Bernoulli, Jenni
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [25] Targeting Estrogen Receptor (ER) Mutations for Treatment of Endocrine Therapy Resistance in Breast Cancer
    Alluri, P. G.
    Larios, J.
    Malik, R.
    Rae, J.
    Chinnaiyan, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S53 - S53
  • [26] Quantitative Progesterone Receptor Expression and Efficacy of Anti-estrogen Therapy in Breast Cancer
    Luoh, Shiuh-Wen
    Ramsey, Betsy
    Park, Byung
    Keenan, Edward
    BREAST JOURNAL, 2014, 20 (01): : 46 - 52
  • [27] Estrogen therapy induces an unfolded protein response to drive cell death in ER plus breast cancer
    Hosford, Sarah R.
    Shee, Kevin
    Wells, Jason D.
    Traphagen, Nicole A.
    Fields, Jennifer L.
    Hampsch, Riley A.
    Kettenbach, Arminja N.
    Demidenko, Eugene
    Miller, Todd W.
    MOLECULAR ONCOLOGY, 2019, 13 (08) : 1778 - 1794
  • [28] Pharmacogenetics of anti-estrogen treatment of breast cancer
    Del Re, Marzia
    Michelucci, Angela
    Simi, Paolo
    Danesi, Romano
    CANCER TREATMENT REVIEWS, 2012, 38 (05) : 442 - 450
  • [29] Effect of hormone replacement therapy on breast cancer risk: Estrogen versus estrogen plus progestin
    Ross, RK
    Paganini-Hill, A
    Wan, PC
    Pike, MC
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (04): : 328 - 332
  • [30] Enhanced efficacy of ARV-471, a novel PROTAC® estrogen receptor degrader, in combination with targeted agents in estrogen receptor-positive (ER plus ) breast cancer models
    Teh, Jessica
    Bortolon, Elizabeth
    Pizzano, Jennifer
    Pannone, Melissa
    Landrette, Sean
    Gedrich, Richard
    Taylor, Ian
    CANCER RESEARCH, 2023, 83 (07)
12345